This inventor holds 2 USPTO granted patents. Top assignee: Other. Active years: 2004-2006.
Company Filing History:
2 out of 834,350 Years Active: 2004-2006
Title: Ray A Ollson: Innovator in Adenosine Receptor Research
Introduction
Ray A Ollson is a notable inventor based in Tampa, FL (US). He has made significant contributions to the field of pharmacology, particularly in the development of compounds that act as allosteric enhancers at human A1 adenosine receptors. With a total of 2 patents, his work is paving the way for new therapeutic methods.
Latest Patents
Ollson's latest patents include innovative compounds such as 2-amino-3-aroyl-4,5 alkylthiophenes. These compounds serve as agonist allosteric enhancers at human A1 adenosine receptors. The invention relates to a compound of formula (I), which provides a therapeutic method for preventing or treating pathological conditions in mammals, including humans. The method involves administering an effective amount of the thiophene selective adenosine A allosteric enhancer to individuals in need of such therapy, particularly where increased angiogenesis is desired.
Career Highlights
Throughout his career, Ray A Ollson has focused on advancing the understanding of adenosine receptors and their potential therapeutic applications. His research has contributed to the development of new treatment options for various medical conditions.
Collaborations
Ollson has collaborated with esteemed colleagues in his field, including Joel M Linden and Peter J Scammells. These partnerships have enhanced the scope and impact of his research.
Conclusion
Ray A Ollson's innovative work in the realm of adenosine receptor research exemplifies the importance of scientific inquiry in developing new therapeutic strategies. His contributions continue to influence the field and hold promise for future advancements.